{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:40:52Z","timestamp":1791103252910,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1007\/s003930070032","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T16:24:01Z","timestamp":1033921441000},"page":"I10-I20","source":"Crossref","is-referenced-by-count":14,"title":["Osteoporose bei rheumatoider Arthritis \u2013 Bedeutung von Alfacalcidol in Pr\u00e4vention und Therapie","Osteoporosis in rheumatoid arthritis \u2013 rationale for alfacalcidol in prevention and therapy"],"prefix":"10.1007","volume":"59","author":[{"given":"E.","family":"Schacht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,10]]},"reference":[{"issue":"5","key":"32_CR1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/art.1780370702","volume":"37","author":"NFA Peel","year":"1994","unstructured":"Peel NFA, Spittlehouse AJ, Bax DE, Eastell R (1994) Bone mineral density of hand in rheumatoid arthritis. Arthritis Rheum 37(5):983\u2013991","journal-title":"Arthritis Rheum"},{"key":"32_CR2","first-page":"149","volume":"55","author":"JD Ringe","year":"1996","unstructured":"Ringe JD (1996) Generalisierte Osteoporose bei chronischer Polyarthritis \u2014 Pathomechanismen und Behandlungsans\u00e4tze. Z Rheumatol 55:149\u2013","journal-title":"Z Rheumatol"},{"key":"32_CR3","first-page":"199","volume":"14","author":"PS Gulko","year":"1996","unstructured":"Gulko PS, Mulloy AL (1996) Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment.Clin Exp Rheumatol 14:199\u2013206","journal-title":"Clin Exp Rheumatol"},{"key":"32_CR4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/ard.46.11.830","volume":"46","author":"RW Mellish","year":"1987","unstructured":"Mellish RW, O'Sullivan MM, Garrahan NJ, Compston JE (1987) Iliac crest trabecular bone mass and structure in patients with non-steroid-treated rheumatoid arthritis.Ann Rheum Dis 46:830\u2013836","journal-title":"Ann Rheum Dis"},{"key":"32_CR5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.53.1.18","volume":"53","author":"H Kr\u00f6ger","year":"1994","unstructured":"Kr\u00f6ger H, Honkanen R, Sarrikoski S, Alhava E (1994) Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis \u2014 a population based study.Ann Rheum Dis 53:18\u201323","journal-title":"Ann Rheum Dis"},{"key":"32_CR6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.54.10.801","volume":"54","author":"NFA Peel","year":"1995","unstructured":"Peel NFA, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis.Ann Rheum Dis 54:801\u2013806","journal-title":"Ann Rheum Dis"},{"key":"32_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ard.54.1.49","volume":"54","author":"C Cooper","year":"1995","unstructured":"Cooper C, Coupland C, Mitchell M (1995) Rheumatoid arthritis, corticosteroid therapy and hip fracture.Ann Rheum Dis 54:49\u201352","journal-title":"Ann Rheum Dis"},{"key":"32_CR8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(94)91049-9","volume":"344","author":"AKS Gough","year":"1994","unstructured":"Gough AKS, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis.Lancet 344:23\u201327","journal-title":"Lancet"},{"key":"32_CR9","first-page":"405","volume-title":"10th Workshop on Vitamin D, Strasbourg, Proceedings","author":"JE Welsh","year":"1997","unstructured":"Welsh JE, Jones WA (1997) 1,25(OH)2D3 protects MG-63 osteoblasts from TNF-\u03b1 and ceramide induced apoptosis.10th Workshop on Vitamin D, Strasbourg, Proceedings: 405\u2013406"},{"key":"32_CR10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/ard.48.6.483","volume":"48","author":"JE Compston","year":"1989","unstructured":"Compston JE, Vedi S, Mellish RWE, Croucher P, O'Sullivan MMO (1989) Reduced bone formation in non-steroid treated patients with rheumatoid arthritis.Ann Rheum Dis 48:483\u2013487","journal-title":"Ann Rheum Dis"},{"issue":"Suppl12","key":"32_CR11","first-page":"21","volume":"13","author":"J Dequeker","year":"1995","unstructured":"Dequeker J, Maenaut K, Verwilghen J, Westhovens R (1995) Osteoporosis in rheumatoid arthritis.Clin Exp Rheumatol 13 (Suppl 12):21\u201326","journal-title":"Clin Exp Rheumatol"},{"key":"32_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2796.1993.tb00738.x","volume":"234","author":"T Olbricht","year":"1993","unstructured":"Olbricht T, Benker G (1993) Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment, with special regard to the rheumatic diseases.J Intern Med 234:237\u2013244","journal-title":"J Intern Med"},{"key":"32_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01623380","volume":"3","author":"P Chavassieux","year":"1993","unstructured":"Chavassieux P, Pastoureau P, Chapuy MC, Delmas PD, Meunier PJ (1993) Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study.Osteoporosis Int 3:97\u2013102","journal-title":"Osteoporosis Int"},{"key":"32_CR14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1210\/endo.136.2.7530648","volume":"136","author":"GA Gronowicz","year":"1995","unstructured":"Gronowicz GA, McCarthy MB (1995) Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease beta-1 integrin levels.Endocrinology 136:598\u2013608","journal-title":"Endocrinology"},{"key":"32_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jbmr.5650070105","volume":"7","author":"M Godschlak","year":"1992","unstructured":"Godschlak M, Levy JR, Downs RW (1992) Glucocorticoids decrease vitamin D receptor numbers and gene expression in human osteosarcoma cells.J Bone Miner Res 7:21\u201327","journal-title":"J Bone Miner Res"},{"issue":"4S","key":"32_CR16","first-page":"31S","volume":"20","author":"PL Selby","year":"1997","unstructured":"Selby PL, Kelsall J, Adams JE, Mee AP, Mawer EB (1997) Are polymorphisms of the vitamin D receptor gene risk factors for corticosteroid induced osteoporosis? Bone 20(4S):31S","journal-title":"Bone"},{"key":"32_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2265.1983.tb03198.x","volume":"18","author":"AA Khaleeli","year":"1983","unstructured":"Khaleeli AA, Edwards CHT, Gohil K et al. (1983) Corticosteroid myopathy: a clinical and pathological study.Clin Endocrinol 18:155\u2013166","journal-title":"Clin Endocrinol"},{"issue":"Suppl2","key":"32_CR18","first-page":"20","volume":"7","author":"K Tanaka","year":"1997","unstructured":"Tanaka K, Natsui K, Suda M, Yasoda A, Sakuma Y, Akamizu T, Ozaki S, Shigeno C, Konishi J, Nakao K (1997) Intensive glucocorticoid treatment induces rapid loss of trabecular bone volume and lean body mass.Osteoporosis 7(Suppl 2):20","journal-title":"Osteoporosis"},{"key":"32_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/ard.52.1.21","volume":"52","author":"RFJM Laan","year":"1993","unstructured":"Laan RFJM, Buijs WCAM, Verbeek ALM et al. (1993) Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity.Ann Rheum Dis 52:21\u201326","journal-title":"Ann Rheum Dis"},{"key":"32_CR20","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1172\/JCI117244","volume":"93","author":"R R ^ Roubenoff","year":"1994","unstructured":"Roubenoff R, Roubenoff RA; Cannon JG et al. (1994) Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.J Clin Invest 93:2379\u20132386","journal-title":"J Clin Invest"},{"key":"32_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0169-6009(08)80128-6","volume":"24","author":"AG Johansson","year":"1994","unstructured":"Johansson AG, Baylink DJ, Ekenstam E, Lindth E, Mohan S, Ljungball S (1994) Circulating levels of insulin-like growth factor-I and -II, and IGF-binding protein-3 in inflammation and after parathyroid hormone infusion.Bone Miner 24:25\u201331","journal-title":"Bone Miner"},{"issue":"3","key":"32_CR22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002239900416","volume":"62","author":"P Oelzner","year":"1997","unstructured":"Oelzner P, M\u00fcller A, Deschner F, H\u00fcller M, Abendroth K, Hein G, Stein G (1997) Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis.Calcif Tissue Int 62(3):193\u2013198","journal-title":"Calcif Tissue Int"},{"key":"32_CR23","first-page":"220","volume":"20","author":"E Ekenstam","year":"1991","unstructured":"Ekenstam E (1991) Influence of inflammation and corticosteroid treatment on indices of bone turnover and parathyroid function.Scand J Rheumatol 20:220","journal-title":"Scand J Rheumatol"},{"key":"32_CR24","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1210\/jcem.83.11.5270","volume":"83","author":"CJ Haug","year":"1998","unstructured":"Haug CJ, Aukrust P, Haug E, Morkrid L, M\u00fcller F, Froland SS (1998) Severe deficiency of 1,25-Dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis.J Clin Endocrinol Metab 83:3832\u20133838","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR25","first-page":"17","volume":"15\/2","author":"E Schacht","year":"1995","unstructured":"Schacht E (1995) Neue Aspekte der Immunmodulation bei der rheumatoiden Arthritis: arthritis+rheuma 15\/2:17\u201330","journal-title":"Neue Aspekte der Immunmodulation bei der rheumatoiden Arthritis: arthritis+rheuma"},{"key":"32_CR26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0003-9993(99)90307-6","volume":"80","author":"HA Bischoff","year":"1999","unstructured":"Bischoff HA, Stahelin HB, Urscheler N, Ehrsam R, Vonthein R, PerrigChiello P, Tyndall A, Theiler R (1999) Archives of physical medicine and rehabilitation 80:54\u201358","journal-title":"Archives of physical medicine and rehabilitation"},{"key":"32_CR27","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1210\/endo-129-6-3139","volume":"129","author":"SH Scharla","year":"1991","unstructured":"Scharla SH, Strong DD, Mohan S, Baylink DJ, Linkhart TA (1991) 1,25-dihydroxyvitamin D3 differentially regulates the production of IGF-I and IGFBP-4 in mouse osteoblasts.Endocrinology 129:3139\u20133146","journal-title":"Endocrinology"},{"key":"32_CR28","first-page":"4111","volume":"83","author":"RP Heaney","year":"1997","unstructured":"Heaney RP, Barger-Lux MJ, Dowell MS, Chen TC, Holick MF (1997) Calcium absorptive effects of vitamin D and its major metabolites.J Clin Endocrinol Metab 83:4111\u20134116","journal-title":"J Clin Endocrinol Metab"},{"key":"32_CR29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s002239900195","volume":"60","author":"K Akesson","year":"1997","unstructured":"Akesson K, Lau KHW, Baylink DJ (1997) Rational for active vitamin D analog therapy in senile osteoporosis.Calcif Tissue Int 60:100\u2013105","journal-title":"Calcif Tissue Int"},{"issue":"Suppl1","key":"32_CR30","first-page":"69","volume":"101","author":"SH Scharla","year":"1993","unstructured":"Scharla SH, Strong DD, Mohan S, Linkhart TA (1993) Effect of 1,25-dihydroxyvitamin D3 on the secretion of insulin-like growth factor-II (IGF-II) and IGF-binding proteins (IGFBPs) in human osteoblast-like cells.Exp Clin Endocrinol 101 (Suppl 1):69","journal-title":"Exp Clin Endocrinol"},{"key":"32_CR31","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.4049\/jimmunol.160.11.5314","volume":"160","author":"MT Cantorna","year":"1998","unstructured":"Cantorna MT, Woodward WD, Hayes CE, DeLuca HF (1998) 1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-b1 and IL-4.Journal of Immunology 160:5314\u20135319","journal-title":"Journal of Immunology"},{"key":"32_CR32","first-page":"236","volume":"60","author":"I Zofkov\u00e1","year":"1997","unstructured":"Zofkov\u00e1 I, Kancheva RL, Bendlov\u00e1 B (1997) Effect of 1,25(OH)2 vitamin D3 on circulating insulin-like growth factor- I and \u03b22 microglobulin in patients with osteoporosis.CalcifTissue Int 60:236\u2013239","journal-title":"CalcifTissue Int"},{"key":"32_CR33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF01621905","volume":"3","author":"Y Seino","year":"1993","unstructured":"Seino Y, Ishizuka S, Shima M, Tanaka H (1993) Vitamin D in bone formation.Osteoporosis Int 3:196\u2013198","journal-title":"Osteoporosis Int"},{"key":"32_CR34","first-page":"18","volume-title":"Osteoporose und aktive Vitamin D-Metabolite: Ein Blick in die Zukunft","author":"MA Dambacher","year":"1996","unstructured":"Dambacher MA, Schacht E (1996) Osteoporose und aktive Vitamin D-Metabolite: Ein Blick in die Zukunft. EULAR Verlag Basel: Litera Rheumatologica 18"},{"key":"32_CR35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/8756-3282(92)90010-T","volume":"13","author":"MT Zarrabeitia","year":"1992","unstructured":"Zarrabeitia MT, Riancho JA, Amado JA, Olmos JM, Gonzalez-Macias J (1992) Effect of calcitriol on the secretion of prostagladin E2, interleukin 1 and tumor necrosis factor \u03b1 by human monocystes.Bone 13:185\u2013189","journal-title":"Bone"},{"issue":"6","key":"32_CR36","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/1043-4666(92)90012-G","volume":"4","author":"K M\u00fcller","year":"1992","unstructured":"M\u00fcller K, Haahr PM, Diamant M, Rieneck K, Kharazmi A, Bendtzen K (1992) 1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level.Cytokine 4(6):506\u2013512","journal-title":"Cytokine"},{"key":"32_CR37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0169-6009(89)90072-X","volume":"7","author":"UG Lempert","year":"1989","unstructured":"Lempert UG, Minne HW, Albrecht B, Scharla SH, Matthes F, Ziegler R (1989) 1,25-dihydroxy-vitamin D3 prevents the decrease of bone mineral appositional rate in rats with inflammation-mediated osteopenia (IMO).Bone Miner 7:149\u2013158","journal-title":"Bone Miner"},{"key":"32_CR38","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/edrv-7-4-434","volume":"7","author":"R Boland","year":"1986","unstructured":"Boland R (1986) Role of vitamin D in skeletal muscle function.Endocr Rev 7:434\u2013448","journal-title":"Endocr Rev"},{"key":"32_CR39","first-page":"106","volume-title":"10th Workshop on Vitamin D, Strasbourg. Abstract","author":"H Glerup","year":"1997","unstructured":"Glerup H, Andersen H, Clausen T, Eriksen EF (1997) Osteomalacia is characterised by low concentrations of Ca-ATPase in striated muscles. Normalisation after treatment with vitamin-D is associated with increased muscle power. 10th Workshop on Vitamin D, Strasbourg. Abstract: 106"},{"issue":"3","key":"32_CR40","first-page":"157","volume":"18","author":"GL Bach","year":"1998","unstructured":"Bach GL, Scharla S, Schacht E (1998) Osteoporose: neue Erkenntnisse einer physiologischen Therapie. arthritis+rheuma 18(3):157\u2013163","journal-title":"Osteoporose: neue Erkenntnisse einer physiologischen Therapie. arthritis+rheuma"},{"issue":"1\u20136","key":"32_CR41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0960-0760(95)00106-A","volume":"53","author":"JM Lemire","year":"1995","unstructured":"Lemire JM (1995) Immunomodulatory actions of 1,25-dihydroxyvitamin D3.J Steroid Biochem Molec Biol Vol 53, 1\u20136:599\u2013602","journal-title":"J Steroid Biochem Molec Biol Vol"},{"issue":"1","key":"32_CR42","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s000110050042","volume":"46","author":"G Michel","year":"1997","unstructured":"Michel G, Gailis A, Jarzebska-Deussen B, Mueschen A, Mirmohammadsadegh A, Ruzicka T (1997) 1,25-(OH)2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells.Inflammation Research 46(1):32\u201334","journal-title":"Inflammation Research"},{"issue":"2","key":"32_CR43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0024-3205(97)00369-X","volume":"61","author":"I Zofkov\u00e1","year":"1997","unstructured":"Zofkov\u00e1 I, Kancheva RL (1997) The effect of 12,5(OH)2-vitamin D3 on CD3+\/CD8+ subsets of T lymphocytes in postmenopausal women.Life Sci 61(2):147\u2013152","journal-title":"Life Sci"},{"key":"32_CR44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/jn\/128.1.68","volume":"128","author":"MT Cantorna","year":"1998","unstructured":"Cantorna MT, Hayes CE, DeLuca HF (1998) 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis.J Nutr 128:68\u201372","journal-title":"J Nutr"},{"key":"32_CR45","first-page":"33","volume-title":"Rheum Eur","author":"Z Andelkovic","year":"1996","unstructured":"Andelkovic Z, Vojinovic J, Pejnovic N, Popovic M (1996) Immunomodulatory effects of high oral dose Alpha D3 in rheumatoid arthritis patients.Rheum Eur (Suppl 1) Vol 25:33"},{"key":"32_CR46","first-page":"5","volume-title":"Osteologie","author":"MA Dambacher","year":"1998","unstructured":"Dambacher MA, Schacht E (1998) Aktive Vitamin D-Metabolite (D-Hormone) in der Osteoporose-Therapie auf der Basis neuer Erkenntnisse zur Pathogenese.Osteologie 5\u201325"},{"key":"32_CR47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s001980050118","volume":"9","author":"JY Reginster","year":"1999","unstructured":"Reginster JY, Kuntz D, Verdickt W, Wouters M, Guillevin L, Menk\u00e8s CJ, Nielsen K (1999) Prophylacic use of alfacalcidol in corticosteroid-induced osteoporosis.Osteoporos Int 9:75\u201381","journal-title":"Osteoporos Int"},{"issue":"6","key":"32_CR48","first-page":"995","volume":"23","author":"JD Adachi","year":"1996","unstructured":"Adachi JD, Bensen WG, Bianchi F, Cividino A, Pillersdorf S, Sebaldt JS, Tugwell P, Gordon M, Steele M, Webber C, Goldsmith CH (1996) Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.J Rheumatol 23(6):995\u20131000","journal-title":"J Rheumatol"},{"issue":"10","key":"32_CR49","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/00007890-199605270-00015","volume":"61","author":"J Cleemput Van","year":"1996","unstructured":"Van Cleemput J, Daenen W, Geusens P, Dequeker J, van de Werf F, Vanhaecke J (1996) Prevention of bone loss in cardiac transplant recipients.Transplantation 61(10):1495\u20131499","journal-title":"Transplantation"},{"key":"32_CR50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00041552-199507000-00005","volume":"4","author":"K Casteels","year":"1995","unstructured":"Casteels K, Bouillon R, Waer M, Mathieu C (1995) Immunomodulatory effects of 1,25-dihydroxyvitamin D3.Curr Opin Nephrol Hypertens 4:313\u2013318","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s003930070032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s003930070032\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s003930070032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T19:51:08Z","timestamp":1680637868000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s003930070032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":50,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["32"],"URL":"https:\/\/doi.org\/10.1007\/s003930070032","relation":{},"ISSN":["0340-1855"],"issn-type":[{"value":"0340-1855","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}